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Background: Malaria is one of the greatest health challenges worldwide threatening millions of people especially 
children in sub Saharan Africa. Cylicodiscus gabunensis (Taub.) Harms (Mimosaceae) is a tree plant of Tropical Africa 
used in traditional medicine for the treatment of malaria and other diseases. 
Objective: The objective of this work was to evaluate the antimalarial activities of Cylicodiscus gabunensis stembark 
fractions to ascertain the folkloric claim of its antimalarial activity. 
Methodology: The stembark fractions of Cylicodiscus gabunensis (n-hexane, dichloromethane, ethyl acetate and 
methanol; 40 mg/kg) of C. gabunensis were investigated for antimalarial activities against chloroquine-sensitive 
Plasmodium berghei infections in Swiss albino mice. Chloroquine (5 mg/kg) and pyrimethamine (1.2 mg/kg) were 
used as positive controls. Thin films made from tail blood of each mouse were used to assess the level of parasitaemia.  
Results: The fractions significantly (p<0.01-0.001) reduced parasitaemia in suppressive, prophylactic and curative 
antimalarial mouse models with the chloroform and ethyl acetate fractions exerting the most significant activities 
(p<0.05-0.01) than other fractions. The mean survival time (MST) was significantly (p<0.01-0.001) improved to 20.0 
days compared to control (10.00 days).  
Conclusion: The results indicate that chloroform and ethyl acetate fractions of C. gabunenesis stembark are the most 
potent antimalarial fractions with active antimalarial compounds that can be use as lead to the development of new 
antimalarial drug.    
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1. Introduction 
Cylicodiscus gabunensis (Taub.) Harms (Mimosaceae) 
syn. Erythropleum gabunensis is a large tree, 180–200 ft 
in height, common in the rainforests of West and Central 
Africa (Hutchinson and Daziel, 1968). In folk medicine, 
the stembark is used to treat body pains, fever, 
rheumatism, jaundice and malaria by the Ibibios of Niger 
Delta region of Nigeria. Biological activities reported on 
the stembark include antiplasmodial (Okokon et al, 
2006), antimicrobial (Kouitcheu et al, 2006a), 
antidiarrhoeal (Kouitcheu et al, 2006b), and antioxidant 
(Huang et al, 2009) activities. Okokon et al, (2006) had 
reported LD50 value of 223.6 mg/kg and the presence of 
alkaloids, flavonoids, saponins, terpenes and cardiac 
glycosides in the stembark extract. The stembark has 
been reported to contain triterpene saponin 
(Tchivounda et al, 1990a, 1991), cylicodiscus acid, a 
dihydroxy pentacyclic triterpene carboxylic acid 
(Tchivounda et al, 1990b), coumestan glycosides, 
coumestoside C and coumestoside D (Nchancho et al, 
2009), Gabunoside, an oleanane-type triterpene saponin 
(Tene et al, 2011) and cyclodione, a dimeric diterpene 
(Tane et al, 1995). There is a little information on the 
antiplasmodial efficacy of the stembark in vivo. The 
present investigation was carried out to evaluate the 
antimalarial activities of the various crude stembark 
fractions against Plasmodium berghei berghei infection in 
mice to identify the fraction with antimalarial property 
in bid to localize where the active principle resides. 
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Chloroquine diphosphate and pyrimethamine used in 
this study were from Sigma-Aldrich, Germany. 
2.2 Animals 
The animals (Swiss albino mice) of either sex were used 
for these experiments. The animals were housed in 
standard cages and were maintained on a standard 
pelleted feed (Guinea feed) and water ad libitum. 
Permission and approval for animal studies were 
obtained from the College of Health Sciences Animal 
Ethics Committee, University of Uyo. 
2.3 Microorganism (Parasite) 
A chloroquine sensitive strain of Plasmodium berghei 
(ANKA) was obtained from the National Institute of 
Medical Research (NIMER), Yaba Lagos, Nigeria and was 
maintained by sub-passage in mice (Odetola and Basir, 
1980).  
2.4 Collection of plant materials 
The fresh stembark of Cylicodiscus gabunensis were 
collected in April, 2016 at a farmland in Ikono LGA, Akwa 
Ibom State, Nigeria. The stembark was identified and 
authenticated as Cylicodiscus gabunensis by Dr. Margaret 
Bassey, a taxonomist in the Department of Botany and 
Ecological studies, University of Uyo, Uyo, Nigeria. 
Herbarium specimen (FPUU 383) was deposited at the 
Faculty of Pharmacy Herbarium, University of Uyo, Uyo. 
2.5 Extraction 
The plant parts (stembark) were washed and air- dried 
on laboratory table for 2 weeks. The dried stembarks 
were pulverized using a pestle and mortar. The 
powdered stembark (1.5 kg) was macerated for 72 hours 
successively and gradiently in each of petroleum ether, 
dichloromethane, ethyl acetate and methanol to give the 
corresponding fractions of these solvents. The liquid 
obtained by filtration was evaporated to dryness in a 
rotary evaporator 40˚C. The crude fractions were stored 
in a refrigerator at 4˚C until used for experiment 
reported in this study.  
2.6 Parasite inoculation 
Each mouse used in the experiment was inoculated 
intraperitoneally with 0.2 ml of infected blood 
containing about 1 x 107 P. berghei berghei parasitized 
erythrocytes. The inoculum consisted of 5 x 107 P. 
berghei berghei erythrocytes per ml. This was prepared 
by determining both the percentage parasitaemia and 
the erythrocytes count of the donor mouse and diluting 
the blood with isotonic saline in proportions indicated by 
both determinations (Odetola and Basir, 1980). 
2.7 Drug administration 
The drugs (chloroquine and pyrimethamine) and  extract  
used in the antimalarial study were orally administered 
with the aid of a stainless metallic feeding cannula. 
2.8 Evaluation of in vivo antimalarial activity of 
crude stembark fractions of Cylicodiscus gabunensis 
2.8.1 Evaluation of suppressive activity of the crude 
fractions (4-day test). 
This test was used to evaluate the schizontocidal activity 
of the extract/fractions and chloroquine against early P. 
berghei berghei  infection in mice.  This was done as 
described by Knight and Peters (1980). Thirty six mice 
were randomly divided into six groups of six mice each. 
On the first day (DO), the thirty six mice were infected 
with the parasite and randomly divided into various 
groups. These were administered with the crude 
fractions and chloroquine.The mice in groups 1- 4 were 
administered 40 mg/kg of n-hexane, chloroform, ethyl 
acetate and methanol fractions respectively. Group 5 was 
administered with 5 mg/kg of chloroquine (positive 
control), and 10ml/kg of distilled water to group 6 
(negative control) for four consecutive days (D0 – D3) 
between 8am and 9am. On the fifth day (D4), thin blood 
film was made from tail blood. The film was then stained 
with Giemsa stain to reveal parasitized erythocytes out 
of 500 in a random field of the microscope. The average 
percentage suppression of parasitaemia was calculated 
in comparison with the controls. The mean survival time 
of the mice were monitored in the different groups for 30 
days. 
2.8.2 Evaluation of prophylactic or repository 
activities of crude stembark fractions  
The repository activities of the crude fractions and 
pyrimethamine were assessed using the method 
described by Peters (1965). The mice were randomly 
divided into six groups of six mice each. Groups 1 - 4 were 
administered with 40 mg/kg/day of n-hexane, 
chloroform, ethyl acetate and methanol fractions 
respectively. Groups 5 and 6 were administered with 1.2 
mg/kg/day of pyrimethamine (positive control) and 10 
ml/kg of distilled water (negative control) respectively. 
Administration of the fractions/drug continued for three 
consecutive days (D0 – D2). On the fourth day (D3) the 
mice were inoculated with P. berghei berghei. The 
parasitaemia level was assessed by blood smears 
seventy-two hours later. The mean survival time (MST) 
of the mice in each treatment group was determined over 
a period of 29 days. 
2.8.3 Evaluation of curative activities of crude 
fractions (Rane’s test)  
This was used to evaluate the schizontocidal activity of 
the crude fractions and chloroquine in established 
infection. This was done as described by Ryley and 
Peters (1970). P. berghei  was injected intraperitoneally 
into 36 mice on the first day (DO). Seventy–two hours 
later (D3), the mice was divided randomly into six groups 
of six mice each. Groups 1 - 4 were administered with 40 
mg/kg/day of n-hexane, chloroform, ethyl acetate and 
methanol fractions respectively. 5 mg/kg/day of 
chloroquine was administered to the group 5 (positive 
control) and group 6 was given 10 ml/kg of distilled 
water (negative control).  The crude fractions and drugs 
were administered once daily for 5 days. Giemsa stained 
thin smears were prepared from tail blood samples 
collected on each day of treatment to monitor 
parasitaemia level. The mean survival time (MST) of the 
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mice in each treatment group was determined over a 
period of 29 days (D0 – D28). 
2.9 Phytochemical Screening 
Phytochemical screening of the crude stembark fractions 
were carried out employing standard procedures and 
tests (Trease and Evans, 1989; Sofowora, 1993), to 
reveal the presence of chemical constituents such as 
alkaloids, flavonoids, tannins, terpenes, saponins, 
anthraquinones, reducing sugars, and cardiac glycosides 
and others. 
3.  Results  
Effect on suppressive activities of crude fractions of 
Cylicodiscus   gabunensis 
The crude fractions showed varying degrees of 
chemosuppressive effect on the parasitaemia. These 
effects were statistically significant relative to the 
control (p<0.05 - 0.001). The chemoinhibitory 
percentages ranged from 25.87 to 45.45 (Table 1). 
Chloroform fraction had the highest activity with 
chemosuppression of 65.73% followed by ethyl acetate 
fraction with chemosuppression of 60.13%. The crude 
fractions exhibited a mean survival time range of 13.66± 
2.18 to 26.33±3.66 days, while methanol fraction had 
MST of 26.33±3.66 days. However, the effects of the 
crude fractions were weak compared to that of the 
standard drug, chloroquine, with a chemosuppression of 
74.12% and MST of 30.00±0.00 days. (Table 1). 
Effect on repository activities of crude fractions of 
Cylicodiscus gabunensis 
The crude stembark fractions of C. gabunensis showed 
chemosuppressive effects of 25.92 – 55.55% on the 
parasitaemia and MST range of 16.00±1.00 – 20.00±1.73 
days during prophylactic studies. These effects were 
statistically significant relative to the control (p<0.05-
0.001). Chloroform fraction had the highest activity with 
chemosuppression of 55.55% and MST range of 
20.00±1.73 days. However, these effects were weak 
compared to that of the standard drug, Pyrimethamine, 
with chemosuppression of 78.70%. (Table 2). 
Antimalarial effects of crude fractions of Cylicodiscus 
gabunensis on established infection 
The crude fractions showed varying degrees of 
schizonticidal effect on the parasitaemia. There were 
reductions in the percentage parasitaemia of the crude 
fraction/chloroquine-treated groups compared to that of 
the control in which prominent increases were recorded. 
These reductions were statistically significant relative to 
the control (p<0.05 - 0.001) (Figure 1). The 
chemosuppression range of the crude fractions treated 
groups was 57.62-76.27% on day 7 with the chloroform 
fraction having the highest chemosuppression of 
76.27%. The crude fractions also showed a significant 
(p<0.05 - 0.001), mean survival time (17.66±1.75 – 
20.00±0.00 days) on established infection, and the MST 
value of chloroform and ethyl acetate fractions treated 
groups were 20.00±1.73 and 20.00±0.00 days 
respectively. The chemosuppressive effects of the crude 
fractions were weak compared to that of the standard 
drug, chloroquine (Table 3). 
Phytochemical screening 
The results of the phytochemical screening of the 
stembark fractions of C. gabunensis revealed that the 
presence of chemical constituents such as alkaloids, 
flavonoids, tannins, terpenes, saponins, cardiac 
glycosides all the fractions except that in n-hexane and 
chloroform fractions, saponins and tannins were absent. 
In addition, saponnins were absent in ethyl acetate 
fraction. However, anthraquinones were absent in all the 
fractions (Table 4). 
Table 1: Suppressive activities of stembark fractions of Cylicodiscus gabunensis (4-day test). 
Drug/extract Dose (mg/kg) Parasitaemia % chemosuppression Mean survival Time (days) 
Distilled water 10ml/kg 27.66± 3.71 _ 11.0 ± 1.00 
n-Hexane 40   11.66±2.33b 25.87 18.0 ± 1.52a 
Chloroform 40 14.33±1.20a 65.73 17.00± 2.08b 
Ethyl acetate 40 6.66±1.85c 60.13 13.66± 2.18b 
methanol 40 10.33±2.73b 45.45 26.33± 3.66b 
Chloroquine 5  0.25± 0.06c 74.12 30.00  ± 0.00c 
Values are expressed as mean ±S.E.M. Significance relative to control: ap<0.05; bp<0.01 cp<0.001, n=6. 
Table 2: Repository/Prophylactic activities of stembark fractions of Cylicodiscus gabunensis on Plasmodium berghei 
infection in mice 
Drug/extract Dose (mg/kg) Parasitaemia % chemosuppression Mean survival Time (days) 
Distilled water 10ml/kg 45.66 ± 0.88 _ 9.66 ± 0.88 
n-Hexane 40   15.33 ±3.71b 25.92 17.33 ± 3.71b 
Chloroform 40 15.00±2.46b 55.55 20.00 ± 1.73c 
Ethyl acetate 40 25.00±3.08a 45.37 20.00 ± 5.00c 
Methanol 40 22.33±2.91a 37.03 16.00 ± 1.00a 
Pyrimethamine 1.2 7.66± 4.80c 78.70 24.66 ± 2.72c 
 Values are expressed as mean ±S.E.M. Significance relative to control: ap<0.05; bp<0.01 cp<0.001, n=6. 
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Figure 1: Antimalarial activities of stembark fractions of Cylicodiscus gabunensis 
 
Table 3: Mean Survival Time (MST) of mice receiving different stembark fractions of Cylicodiscus gabunensis during 
established infection 
Drug/extract Dose (mg/kg) MST (days) 
Distilled water 10 ml/kg 10.00±0.57 
n-Hexane 40   17.66 ± 1.75a 
Chloroform 40 20.00 ± 1.73b 
Ethyl acetate 40 20.00 ± 0.00b 
Methanol 40 19.33 ± 1.75b 
Chloroquine 5  26.00 ± 2.08c 
Values are expressed as mean ±S.E.M. Significance relative to control: ap<0.05; bp<0.01 cp<0.001, n=6. 




n-hexane chloroform Ethyl acetate Methanol 
Alkaloids + + + + 
Flavonoids + ++ ++ + 
Saponins - - - + 
Tannins - - + ++ 
Terpenes ++ ++ ++ ++ 
Cardiac glycosides +++ +++ +++ +++ 
Anthraquinones - - - - 
Keys: + - slightly present, ++ - moderately present,  +++ - highly present,  - absent 
4. Discussion 
The stembark of Cylicodiscus gabunensis is used to treat 
body pains, fever, rheumatism, jaundice and malaria by 
the Ibibios of Niger Delta region of Nigeria. The crude 
stembark fractions (n-hexane, chloroform, ethyl acetate 
and methanol) of C. gabunensis were evaluated for 
antimalarial activity against P. berghei berghei infection 
in mice using suppressive, prophylactic and curative 
models. The fractions were also screened for 
phytochemical constituents. The fractions were found to 
possess varying degrees of antimalarial potentials in the 
models tested with chloroform and ethyl acetate 
fractions exerting the most promising activities 
suggesting the localization of the active ingredients in 
these fractions. Phytochemical study of the active 
fractions revealed the presence of alkaloids, flavonoids, 
terpenes and cardiac glycosides. 
Antimalarial screening of plants has implicated alkaloids, 
terpenes and flavonoids in this activity (Philipson and 
Wright, 1990; Christensen and Kharazmi, 2001). These 
compounds were found to be present in the extract 
studied and may be responsible for the observed 
antimalarial activity of the extract, though the active 
principle is yet to be identified. 
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Although the mechanism of action of this extract has not 
been elucidated, flavonoids are known to exert 
antiplasmodial activity by chelating with nucleic acid 
base pairing of the parasite (Lui et al, 1992), thereby 
producing plasmocidal effect. Other modes of action 
include modulation of host immunity to tackle disease 
and inhibition of plasmodial enoyl-ACP reductase (FAB I 
enzyme)—a key regulator of type II fatty synthases (FAS-
II) in P. falciparum (Teffo et al, 2010; Kirmizibekmez et 
al, 2004). Flavonoids may also bind parasite’s 
serinethreonine kinase with high affinity and affect its 
development (Ferreira et al, 2010). Also some plants are 
known to exert antiplasmodial action either by causing 
elevation of red blood cell oxidation (Etkin, 1997) or by 
inhibiting protein synthesis (Kirby et al, 1989). The 
stembark extract and fractions may be acting through 
one of these mechanisms. Besides, antioxidant potentials 
of some plant and natural products especially flavonoids 
have been found to promote schizoniticide activity by 
modulating the cellular signalling pathway (Al-Adhroey 
et al, 2011) and this has been suggested to be responsible 
for their antimalarial activities (Cimanga et al, 2009; 
Ganesh et al, 2012), as elevated free radicals levels are 
common features of malaria disease and are implicated 
in severe malaria complications. The stembark extract of 
C. gabunensis has been reported to possess strong 
antioxidant activity (Huang et al, 2009). This could also 
contribute to the observed antimalarial activity in this 
study. 
5. Conclusion 
The results of this study support the usage of this plant 
in folk medicine as malarial remedy and identified 
chloroform and ethyl acetate as the active fractions. 
Further work is suggested to isolate, identify and 
characterize the active principles from this plant. 
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